Cargando…
Changes in Lymphocyte Subsets Following Multiple Administration of Recombinant Interleukin‐2 plus Recombinant Interferon‐beta or ‐gamma in Tumor‐bearing Mice
Treatment with a combination of recombinant human interleukin‐2 (rHIL‐2) and recombinant mouse interferon‐beta (rIFN‐β) or ‐gamma (rIFN‐γ) showed a significant antitumor effect against sc adenocarcinoma 755 in mice, although treatment with either one alone had almost no effect. The combination of rH...
Autores principales: | Iigo, Masaaki, Nishikata, Ken‐ichi, Nakajima, Yoko, Moriyama, Masami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917796/ https://www.ncbi.nlm.nih.gov/pubmed/2527216 http://dx.doi.org/10.1111/j.1349-7006.1989.tb01675.x |
Ejemplares similares
-
Effects of Antitumor Agents on Subcutaneous Implants and Hepatic Metastases of Colon Carcinoma 26 in Mice
por: Iigo, Masaaki, et al.
Publicado: (1992) -
Effects of interleukin-2 and interferon-alpha A/D treatment on lymphocytes from tumour-bearing mice.
por: Ligo, M., et al.
Publicado: (1989) -
Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells
Publicado: (1989) -
In vivo Antitumor Effects of Fluoropyrimidines on Colon Adenocarcinoma 38 and Enhancement by Leucovorin
por: Iigo, Masaaki, et al.
Publicado: (1992) -
Antiviral and Antigenic Properties of Recombinant Porcine Interferon Gamma
por: Charley, B., et al.
Publicado: (1988)